- Home
- QTRX vs KRRO Comparison
QTRX vs KRRO Comparison
Compare QTRX & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QTRX
- KRRO
- Stock Information
- Founded
- QTRX 2007
- KRRO 2014
- Country
- QTRX United States
- KRRO United States
- Employees
- QTRX N/A
- KRRO N/A
- Industry
- QTRX Biotechnology: Laboratory Analytical Instruments
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- QTRX Industrials
- KRRO Health Care
- Exchange
- QTRX Nasdaq
- KRRO Nasdaq
- Market Cap
- QTRX 223.6M
- KRRO 209.6M
- IPO Year
- QTRX 2017
- KRRO 2019
- Fundamental
- Price
- QTRX $5.28
- KRRO $15.56
- Analyst Decision
- QTRX Buy
- KRRO Strong Buy
- Analyst Count
- QTRX 5
- KRRO 7
- Target Price
- QTRX $16.20
- KRRO $90.67
- AVG Volume (30 Days)
- QTRX 603.8K
- KRRO 102.4K
- Earning Date
- QTRX 05-12-2025
- KRRO 05-07-2025
- Dividend Yield
- QTRX N/A
- KRRO N/A
- EPS Growth
- QTRX N/A
- KRRO N/A
- EPS
- QTRX N/A
- KRRO N/A
- Revenue
- QTRX $137,421,000.00
- KRRO $4,821,000.00
- Revenue This Year
- QTRX $5.22
- KRRO N/A
- Revenue Next Year
- QTRX $15.31
- KRRO $55.56
- P/E Ratio
- QTRX N/A
- KRRO N/A
- Revenue Growth
- QTRX 12.30
- KRRO N/A
- 52 Week Low
- QTRX $4.67
- KRRO $11.13
- 52 Week High
- QTRX $19.18
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- QTRX 41.90
- KRRO 45.62
- Support Level
- QTRX $5.21
- KRRO $13.40
- Resistance Level
- QTRX $5.75
- KRRO $22.15
- Average True Range (ATR)
- QTRX 0.41
- KRRO 2.47
- MACD
- QTRX 0.04
- KRRO 0.07
- Stochastic Oscillator
- QTRX 21.09
- KRRO 24.69
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.